4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-B]PYRIDINE, 95.0%, 250mg

2-(1H-1,2,4-Triazol-1-yl)ethan-1-ol, 95.0%, 5g

5-Chloro-2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

1-[5-(2,3-Dichloro-phenylsulfanyl)-4-nitro-thiophen-2-yl]-ethanone, 95.0%, 50mg

(3-Fluoro-4'-propyl-[1,1'-biphenyl]-4-yl)boronic acid, 95.0%, 25g

5-Iodopyridin-3-amine, 1g

2-nitrofenil-beta-D-glucopiranósido, mínimo 99 %, para bioquímica, 1 g, envase de vidrio

3',5'-Bis(trifluoromethyl)acetophenone>98.0%(GC)25g

Methyl 2,5-difluorobenzoate, 98.0%, 500g

(3-Aminomethyl-piperidin-1-yl)-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-methanone hydrochloride, 95.0%, 100mg

3-(4-Aminophenyl)-2-oxopropanoic acid hydrochloride, 97.0%, 1g

Solución ROTI®Cell Tripsina (1x)

2-Fluoro-4-nitroaniline, 97.0%, 25g